ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Antibiotic utilization and resistance in diarrheagenic Escherichia coli isolated from children under 5 Years in Nakuru County: a case-control study

[version 1; peer review: 2 not approved]
PUBLISHED 31 Aug 2023
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Pathogens gateway.

This article is included in the Antimicrobial Resistance collection.

Abstract

Background: Children under the age of 5 years continue to suffer the ravaging effects of microbial resistance. Majority of the infections associated with this age are of bacterial and viral nature. Highest mortalities in this age group are those associated with enteric and diarrheal diseases. Diarrheagenic Escherichia coli (DEC) is among the leading causes of these diseases due to their ubiquitous nature.
Methods: The study adopted a case-control design and aimed at investigating antibiotic utilization and resistance in DEC strains isolated from children under 5 years in Nakuru County. A total sample size of 384 children were considered. Stool samples from anal swabs were obtained and cultured on Eosin Methylene Blue (EMB). Antimicrobial susceptibility testing was done using the Kirby-Bauer disk diffusion method to segregate the resistant DEC isolates against amoxicillin, ampicillin, erythromycin, cefoxitin and nalidixic acid.
Results: All the DEC (n=192, 100%) strains were resistant to amoxicillin, n=168, 87.5% were resistant to ampicillin, n=156, 81.3% to erythromycin n=72, 37.5% to cefoxitin and only n=64, 33.3% to nalidixic acid. Based on demographic factors, it was that observed self-medication leads among factors contributing to the observed trend in antimicrobial resistance (AMR). Other factors such the length of antibiotic use did not show any level of significance (p<0.05).
Conclusions: Thus, we conclude that a conglomerate of several factors is associated with the rising cases of AMR among the DEC strains. Notably, the use of first-line antibiotics especially the β-lactams poses a critical health concern being the most resisted class of antibiotics. Therefore, the current study unravels the need to remediate the effects of AMR among the DEC strains through proper formulation and implementation of guidelines on antibiotic usage.

Keywords

Escherichia coli, antibiotic resistance, children

Introduction

A significant portion of the global health burden is caused by enteric infections and diarrheal diseases (EIDD), which are frequently found in developing nations and are closely linked to inadequate water supply, sanitation, and hygiene conditions (Saka et al., 2019). The prevalence of EIDD is high throughout the world and is a major cause of morbidity and mortality in developing nations, with higher rates among children and the elderly. Notably, various microbial agents, such as viruses, bacteria, and parasites, are capable of causing diarrhea. Escherichia coli, belonging to the Enterobacteriaceae family (Wallace et al., 2020), is one of the most frequent bacterial causes of diarrhea among children under 5 years of age.

Up to 40% of all diarrheagenic cases in developing nations are caused by strains of diarrhoeagenic E. coli (DEC), including enteropathogenic E. coli (EPEC), enteroaggregative E. coli (EAEC), and enterotoxigenic E. coli (ETEC), with an estimated 2.5 million child fatalities worldwide (Raghavan et al., 2017). Antibiotics have always been used to manage and treat enteric infections and diarrheal diseases (EIDD) majorly caused by DEC strains. Resistance patterns are currently on the rise among clinical cases of diarrhea in children under the age of five. These cases have been linked to the current emergence of new strains that are resistant to antibiotics. According to the World Health Organization [WHO] (2017), multi-drug resistance among important medical bacteria, including DEC, is causing global concern. Resistance to several antibiotics is largely caused by genetic mutations in bacteria allowing them to evade the lethal effects of these antibiotics (Verstraete et al., 2022). However, the acquisition of mobile genetic elements, such as gene cassettes, integrons, and mobile genetic elements, is connected to the use of third-generation cephalosporins and β-lactams (amoxicillin or ampicillin) (Rozwadowski & Gawel, 2022).

Cephalosporin resistance has been linked to extended-spectrum β-lactamases (ESBLs), enzymes involved in the degradation of β-lactams (Ali et al., 2018). Numerous asymptomatic DEC infections have been documented as a result of DEC’s widespread distribution, which is frequently characterized by the development of DEC-specific antibodies in young children (Buskirk et al., 2022). Children in DEC-prone and endemic areas, including urban slums, have been observed to experience this phenomenon. Kenya, one of Africa’s developing nations, deals with the threat of DEC antimicrobial resistance brought among children under the age of 5 years (Gitahi et al., 2018; Leting et al., 2022). Due to their multi-drug resistance, these resistant bacterial strains are proving challenging to control. In Kenya, just like other countries globally, drug-resistant pathogens are primarily caused by the improper and excessive use of antibiotics (Webale et al., 2020). This study, therefore, investigated the cases of multi-drug resistance in children under the age of five with prior use of the selected antibiotic agents in Nakuru County.

Methods

Study site

This study was conducted at the Nakuru County General Hospital, specifically in the in-patient and out-patient departments. The geographical location of Nakuru County makes it a suitable location to investigate antibiotic utilization and resistance in diarrheagenic Escherichia coli, as it is an area with high rates of diarrheal diseases. Additionally, the high patient turnover at the hospital made it easier to obtain the required sample size for the study. The data were collected between October 2017 and May 2019.

Ethical considerations

The study received ethical approval from the KNH-UoN ERC (reference number KNH-ERC/A/216) on July 12, 2017, and research authorization from NACOSTI (reference number NACOSTI/P/22/20744) on 30th August 2017. Permission was also obtained from the County Medical Director and Public Health, as well as the Hospital Medical Superintendent of Nakuru Provincial General Hospital (Ref No. RII/Vol 1/08) on 24th October 2017. Caregivers provided informed consent for their children to participate by signing a consent form. Data collection was confined to the specified study period.

The study design

To investigate risk factors linked to antibiotic resistance, a case-control study design according to (Schlesselman, 1982) was used. Children who had developed an outcome (antimicrobial resistance) were identified in a case-control study, and their previous exposure to putative etiological factors was compared to that of controls or referents who did not have antimicrobial resistance. The starting point of a case-control study was the identification of cases.

Selection of cases and controls

Children under the age of five from Nakuru County and whose parents or legal caregivers signed assent forms constituted the study’s target group. Any subject who had diarrheal episodes 2 weeks preceding sample collection was excluded. To account for confounding variables, a matched design was utilized. Age, sex, diarrhea type, and residence were used to match participants.

Sample size determination and selection

A web-based calculator was used to compute sample size (Philippe 2003). Random sampling technique was employed to select subjects. All children under the age of five who visited the Nakuru provincial general hospital with diarrheagenic Escherichia coli had their stool samples taken to identify cases and controls. A total sample size of 384 children were sampled. As a result, n equals 384 children, and the number of pairs equals 192.

The data collection procedures

Samples were collected between July 12th 2017 to July 11th, 2018. Before the clients were assessed by the clinicians, the researcher assisted in identifying prospective eligible clients with the help of a trained clinic staff. Each child and his or her guardian were referred to the researchers, who explained to them about the study and requested them to sign a consent form. Participation in the study was voluntary.

Validity and reliability

A pre-test was conducted at Kabarnet Hospital in Baringo County. Findings from the study were leveraged to standardize and validate the research instruments. For the computation of the instrument’s dependability, Cronbach’s Coefficient Alpha (α) was employed. A Cronbach’s Coefficient Alpha (α) of 0.75 was achieved which indicated that the instrument was reliable.

Sample collection, isolation, identification, and characterization

The anal swabs were collected under sterile conditions while the participants were lying on their backs. Each swab was assigned a unique participant number before being obtained. A sterile cotton-tipped swab was gently inserted into the anal canal, but not more than one inch, before being withdrawn. The anal swab was then placed into a plastic casing containing Amies transport media (Oxoid, Basingstoke, UK), which helps preserve the microorganisms in a viable but slow growth state during transportation to the laboratory. Subsequently, portions of the sample were transferred to a special container containing Cary-Blair transport medium (ThermoFisher Scientific), stored at 4°C, and sent to the laboratory for analysis.

Isolated E. coli strains were transferred into sterile tubes containing buffered peptone water (P6682-500ML, Sigma Aldrich), a non-selective enrichment media. The swabs were rolled several times onto the sides of the tube to wash off all bacteria from the swab into the tube and the tube containing buffered peptone rinse water. The inoculated buffered peptone rinse solution was incubated at 37°C for 3–4 hours. Subsequently, 200 μl of peptone water cultures were streaked on Eosin Methylene Blue (EMB) agar (Oxoid, Basingstoke, UK) and incubated overnight at 37°C for 24 hours. The plates were removed from the incubator after 24 hours and visually examined to presumptively identify E. coli colonies. Gram staining was done by first heat fixing the bacterial smear on a microscope slide, followed by flooding the slide with crystal violet for one minute. The slide was then rinsed with water and flooded with iodine solution for one minute, followed by rinsing with water again. The slide was then decolorized with alcohol for a few seconds, rinsed with water, and counterstained with safranin for one minute. The slide was then rinsed, air-dried, and examined under oil immersion using a microscope (Smith & Hussey, 2005). To determine the morphology of the growing colonies, a pure culture was obtained by sub-culturing a single E. coli colony on another EMB agar plate. The plate was then incubated at 37°C for 24 hours. A single colony was then selected for confirmative identification of E. coli through a series of biochemical tests. IMViC biochemical tests were done by inoculating a pure culture of E. coli in the appropriate media for each test. Indole production was detected by adding Kovac’s reagent to a culture in Tryptone broth. Methyl red test was performed by adding Methyl red reagent to a culture in MR-VP broth. Voges-Proskauer test was performed by adding Barritt’s A and B reagents to a culture in MR-VP broth. Citrate utilization was determined by inoculating E. coli in Simmons citrate agar. Urease activity was determined by inoculating E. coli in urea agar. The tests were interpreted according to the results obtained by Cheesbrough (2006). Isolates that were positive to Indole and Methyl Red tests but negative to Voges Proskauer, Citrate and Urease tests were identified as E. coli. Escherichia coli ATCC 25922 and K. pneumonia were used as negative and positive controls respectively. Genetic characterization of diarrheagenic E. coli was done by amplification of target genes using polymerase chain reaction (PCR) as described by Shetty et al. (2012) and Fujioka et al. (2013). The target genes used for the identification of the different pathotypes of DEC were InvE for enteroinvasive E. coli (EIEC), st and lt for enterotoxigenic E. coli (ETEC), eaeA for enteropathogenic E. coli (EPEC), and astA for entero-aggregative E. coli (EAEC). PCR products were visualized on agarose gels and analyzed to determine the presence of target genes, which allowed for the identification of the different pathotypes of DEC.

Antimicrobial susceptibility testing

The Kirby-Bauer disk diffusion method was used to test the susceptibility of the isolated E. coli to antibiotics commonly used in animal and human health as described by Hudzicki (2009). The Mueller-Hinton (MH) agar (Oxoid, UK) was utilized according to the recommendations provided by the Clinical Laboratory Standards Institute (CLSI) to perform antimicrobial sensitivity testing. The microorganisms were subjected to testing on disks containing frequently used antimicrobials to assess their susceptibility. Penicillin/Amoxicillin (Oxoid, UK) The inoculum of each E. coli isolate was adjusted to a concentration of about 106 CFU/mL by comparing its turbidity to that of McFarland standard 0.5. Adjusted bacterial inocula were inoculated on the whole surface of the media. The disks were then placed upside down on the inoculated culture plates and the inoculated agar plates were incubated at 37°C for 18 hours. The zones of complete inhibition, along with the disk diameter, were measured using Vanier calipers. The Petri dish was placed above a black, non-reflective surface that was illuminated by reflected light. The edge where no visible growth was observed was considered the zone boundary, which was measured to the nearest millimeter. Disk susceptibility results were interpreted using criteria established by the Clinical and Laboratory Standards Institute (CLSI, 2006).

Statistical analysis

The data obtained was analyzed using SPSS version 25 software. Descriptive statistics, including frequencies and percentages, were employed to summarize the patterns of antibiotic utilization and resistance, as well as the susceptibility of DEC to antibiotics. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were calculated to measure the strength of association between the exposure of children to antibiotics within the past 12 months and antimicrobial resistance. A p-value of less than 0.05 was considered statistically significant.

Results

Figure 1 depicts a graphical distribution of resistant cases. All DEC samples were resistant to amoxicillin while only 12.5% of DEC samples were susceptible to ampicillin (Suge, 2023). Further, the DEC strains from the samples were 81.3%, 37.5% and 33.3% resistant to erythromycin, cefoxitin and nalidixic acid respectively (Table 1). Resistance was noted to decrease moving from β-lactam antibiotics through macrolides to cephalosporins and quinolones.

1677a8b3-e59a-468c-a911-6ea74980bb51_figure1.gif

Figure 1. Resistant patterns of the isolated diarrheagenic Escherichia coli.

Table 1. DEC Antibiotic Susceptibility.

AntibioticsResistant casesSusceptible cases
Amoxicillin192 (100%)0 (0%)
Ampicillin168 (87.5%)24 (12.5%)
Erythromycin156 (81.3%)36 (18.8%)
Cefoxitin72 (37.5%)120 (62.5%)
Nalidixic Acid64 (33.3%)128 (66.7%)

The analysis observed that the number of respondents whose children used antibiotics within the last 12 months was 384 (100%). This is an indication that all the children in Nakuru were frequent users or had been exposed to antibiotics within the study period (2017/2018). The study results also indicated that 148 (38.5%) children consumed antibiotics acquired over the counter and that 236 (61.5%) children in Nakuru county consumed prescription acquired antibiotics (see Table 2).

Table 2. Utilization of antibiotics (for both cases and controls).

Risk factorCategoryFrequencyPercentValid percentCumulative percent
1.Has the child had any experiences with use of antibiotics within the past 12 months?Yes384100100100
2.How was the antibiotic mostly obtained?Over the counter14838.538.538.5
Prescribed23661.561.5100
3.Which was the major antibiotic used during medication/self-medication?None4411.511.511.5
Beta-lactam antibiotics24864.664.676
Macrolides4010.410.486.5
Sulfonamides164.24.290.6
Quinolones369.49.4100
4.How long was the child on Antibiotics?Less than one week288757575
More than a week962525100
5.How often was it if the child was on medication/self-medication with antibiotics?Rarely when sick15640.640.640.6
Sometimes when sick192505090.6
Always when sick369.49.4100
6.Satisfaction with experience of medication with antibioticsUnsatisfied14437.537.537.5
Satisfied24063.563.5100
7.When using antibiotics, how often did the child finish the full prescription? Would you say you always, sometimes, rarely finish all the prescription?Always287.37.37.3
Sometimes20854.254.261.5
Rarely14838.538.5100
8.How often do you make an informed decision that an antibiotic is needed for the child's illness?Always on your own14036.536.536.5
Sometimes on your own24463.563.5100
9.Based on your experience, do you foresee making a personal decision on using antibiotics on your child in future?Yes20052.152.152.1
No18447.947.9100

From the analysis, it can be observed that the β-lactam antibiotics were the most used antibiotics in Nakuru (248, 64.6%). The results also indicate that sulfonamides were the least used antibiotics drug (16, 4.2%). The study further shows that most children used antibiotics for less than one week, with 288 (75%) of the total respondents. While 96 (25%) indicated usage of more than one week. Consequently, it can be observed that 156 (40.6%) of the children were on medication/self-medication with antibiotics when rarely sick. While 192 (50%) of the children were on medication/self-medication with antibiotics sometimes when they were sick. Finally, it can be observed that 36 (9.4%) of the children were on medication/self-medication with antibiotics always when sick. This show that there is a substantial proportion (90.6%) of the children who are on medication/self-medication with antibiotics (see Table 2).

Based on the level of satisfaction, 140 (36.5%) parents indicated that they were not satisfied, while 244 (63.5%) of the respondents recorded that they were satisfied. Further, 148 (38.5%) of the children rarely finished the full prescription when using antibiotics. The study also indicates that 236 (61.5%) of the children within Nakuru always or sometimes finished the full prescription when using antibiotics (see Table 2).

Furthermore, 140 (36.5%) of the respondents indicated that they always made an informed decision that an antibiotic was needed for the child’s illness. The results also indicated that 244 (63.5%) of the respondents sometimes decided on their own that an antibiotic was needed for the child’s illness (see Table 2).

Finally, 200 (52.1%) of the respondents, based on experience, would make personal decisions on using antibiotics in the future. The results also indicate that 184 (47.9%) of the respondents do not foresee making a personal decision on using antibiotics on children in the future (see Table 2).

The analysis showed that the likelihood of a child occasionally completing the entire antibiotic prescription was 1.439 (0.605, 3.425), with a p-value of 0.000, which is significant at the 0.05 level. This odds ratio tells us that individuals who finished the full prescription of antibiotics were not a risk factor for antimicrobial resistance. The results also indicate that the odds of rarely a child finishing the full prescription was 6.75(2.754, 16.546), a p-value = 0.000< 0.05 significant level. This odds ratio tells us that individuals who rarely finished the full prescription of antibiotics have seven times the odds of antimicrobial resistance than individuals who always finished the full prescription (see Table 2).

The results also indicate that the odds of always making an informed decision on their own that antibiotics were needed for the child’s illness was 1.31(0.864, 1.988) with a p-value = 0.122 > 0.05. This odds ratio tells us that individuals who always made an informed decision on their own that antibiotics are needed for the child’s illness were not a risk factor for antimicrobial resistance (see Table 2).

The results showed that the odds to foresee making a personal decision on antibiotic use was 0.3 (0.197, 0.456) with a p-value = 0.000 < 0.05 significant level. Thus, the odds of antimicrobial resistance among individuals who foresee making a personal decision on antibiotic use was only 0.3 times the odds among individuals who did not foresee making a personal decision. This adjusted odds ratio indicates that individuals who foresee making a personal decision on antibiotic use seem to be protective against antimicrobial resistance (see Table 2).

The results show that the odds of how the antibiotic was acquired was 2.692 (1.759, 4.122) with a p-value = 0.000 < 0.05 significant level. These odds show that individuals who obtained antibiotics by walking into a pharmacy without a prescription have three times the odds of antimicrobial resistance than individuals who obtained antibiotics by walking into a pharmacy with a prescription. The results also indicate that the odds of β-lactam 6.167(4.076, 9.330) with a p-value = 0.000 < 0.05 significant level. This odds ratio tells us that individuals who used β-lactams antibiotics during medication/self-medication have six times the odds of antimicrobial resistance than individuals who didn’t use them. The results also indicate that the odds of macrolides 0.909 (0.581, 1.423) with a p-value = 0.422 > 0.05 significant level. This odds ratio tells us that individuals who used macrolides antibiotics during medication/self-medication were not a risk factor for antimicrobial resistance. The results also indicate that the odds of sulfonamide 0.35 (0.184, 0.667) a p-value = 0.000 < 0.05 significant level. Thus, the odds of antimicrobial resistance among individuals who used sulfonamide antibiotics during medication/self-medication were only 0.35 times the odds among individuals who didn’t use them. This adjusted odds ratio tells us that the use of sulfonamide antibiotics during medication/self-medication seems to be protective against antimicrobial resistance. The results also indicate that the odds of quinolones 0.818 (0.529, 1.265) a p-value = 0.25 > 0.05 significant level. This odds ratio tells us that individuals who used quinolones antibiotics during medication/self-medication were not a risk factor for antimicrobial resistance (see Table 3).

Table 3. Association between antimicrobial resistance and exposure of children to antibiotics within the past 12 months.

Risk FactorCharacteristics/Risk factorsCases, n = 192Controls, n = 192Adjusted odds ratio (95% CI)p value
1.How the antibiotic was mostly obtained?Prescribed14096Ref
Over the counter52962.692 (1.759,4.122)0.000
2.Which was the major antibiotic used during medication/self-medication?None2420Ref
Beta-lactam antibiotics1201286.167 (4.076,9.330)0.000
Macrolides20200.909 (0.581,1.4230.422
Sulfonamides880.35 (0.184,0.667)0.000
Quinolones20160.818 (0.529,1.265)0.250
3.How long was the child on Antibiotics?More than a week5244Ref
Less than one week1401480.8 (0.504,1.2720.205
4.How often was it if the child was on medication/self-medication with antibiotics?Rarely when sick324Ref
Sometimes when sick124680.228 (0.077,0.672)0.000
Always when sick361200.038 (0.012,0.113)0.000
5.Satisfaction with experience of medication with antibioticsCompletely satisfied & Satisfied15284Ref
Unsatisfied401044.705 (2.995,7.391)0.000
6.When using antibiotics, how often did the child finish the full prescription? Would you say you always, sometimes, rarely finish all of the prescription?Always208Ref
Some times132761.439 (0.605,3.425)0.272
Rarely401086.75 (2.754,16.546)0.000
7.How often do you make an informed decision that an antibiotic is needed for the child's illness?Sometimes on your own116128Ref
Always on your own76641.31 (0.864,1.988)0.122
8.Based on your experience, do you foresee making a personal decision on using antibiotics on your child in the future?No12064Ref
Yes721280.3 (0.197,0.456)0.000

The results indicate that the odds on the length of usage of antibiotics by the child of less than a week was 0.8 (0.504, 1.272) a p-value = 0.205 > 0.05 significant level. This odds ratio tells us that the length of usage of antibiotics for a period of less than one week was not at risk factor for antimicrobial resistance (see Table 3).

The results indicate that the odds of sometimes a child being on medication/self-medication with antibiotics when sick was 0.228 (0.077, 0.672) a p-value = 0.000 < 0.05 significant level. The results also indicate that the odds of a child always being on medication/self-medication with antibiotics when sick was 0.038 (0.012, 0.113)), a p-value = 0.000 < 0.05 significant level. Thus, the odds of antimicrobial resistance among individuals who sometimes/always had their child being on medication/self-medication with antibiotics when sick was only 0.23 and 0.038 times, respectively, the odds among individuals who rarely had their child on medication/self-medication with antibiotics when sick. This adjusted odds ratio tells us that individuals who sometimes/always had their child being on medication/self-medication with antibiotics when sick seems to be protective against antimicrobial resistance (see Table 3).

The results indicate that the odds of unsatisfaction with experience of antibiotic medication was 4.705 (2.995, 7.391) a p-value = 0.000 < 0.05 significant level. This odds ratio tells us that individuals who were unsatisfied with the use of antibiotic medication have five times the odds of antimicrobial resistance than individuals who were satisfied with antibiotic medication (see Table 3).

Discussion

Particularly in developing nations, DEC poses a concern to children’s health. In this study, 384 children under the age 5 years with acute diarrhea from Nakuru Provincial General Hospital (NPGH) were assessed for the incidence of DEC, epidemiological traits, and patterns of drug resistance. The DEC isolates showed the highest resistance to amoxicillin followed by ampicillin, erythromycin, cefoxitin and nalidixic acid.

Our findings generally indicated that first-line antibiotics, such as ampicillin, were more resistant to DEC infection than second-line antibiotics, such as erythromycin, cefoxitin, and nalidixic acid. Notably, there exist a six-fold risk of developing antimicrobial resistance for individuals who used β-lactams antibiotics during medication/self-medication than those who did not use them. Both previous and current studies concur with these findings (Eltai et al., 2020; Cannatelli et al., 2016; Aslani et al., 2011; Jafari et al., 2009). Due to their affordability (mostly, because they are readily available over the counter) and accessibility first-line antibiotics are frequently, empirically and indiscriminately used to treat diarrhea in developing nations (Shah et al., 2016).

Interestingly, at least all the children in this study had prior exposure to antibiotics within 12 months of birth. There are several studies that support this finding (Marra et al., 2009; Scott et al., 2016). This observation could be attributed to several factors including sensitivity of the immune system during childhood, teething and general propensity of children to harbor diverse pathogens.

Additionally, a large proportion of the children sampled obtained antibiotics directly from pharmacies without prescriptions. Seemingly, the policies governing the use of antibiotics are flawed. It is evident that most African countries, including Kenya, have non-stringent regulations regarding the use of antibiotics. Due to the need to maximize the profit margins and ensure constant flow of medicines, pharmacies tend to bend the regulations to meet such demands. Several studies have observed this tradition. Compounding this observation, most first line antibiotics, more specifically β-lactams (in case of the current study) are the mostly used. However, sulfonamides account for only a small fraction of the total medications used during treatment. The availability of and affordability of the first line antibiotics could be largely attributed to these observations. Several studies have been able to explain this trend in many populations. For example, a study by Erku et al. (2017) demonstrated that amoxicillin was the most commonly utilized antibiotic due to its easy acquisitions and affordability. Also, Saleem et al. (2019), while exploring the use of antibiotics inappropriately by Pakistani hospital patients, observed a significant use of cephalosporins and penicillin and thus their potential risk of developing resistance against them. A similar study by Okubo et al. (2018) also supports this observation. Also, Singh et al. (2018) showed the existence of a high prevalence of antibiotic resistance to widely used drugs like ampicillin, ceftazidime, cefoxitin, streptomycin, and tetracycline.

Notably, the duration of use of antibiotics seems to be a factor contributing overall to the emergence of resistance among the sample population. Only a quarter of the population used medications past one week. In contrast, the majority of the sampled population used antibiotics for less than seven days. Most of the antibiotics that are correctly prescribed are more than a week. This observation indicates that the majority of the children could be withdrawn of their medications when their caregivers/parents observe their improved health status. Also, based on the data of how often a child finishes the entire prescription, it was noted only 7% finished their medications. As it is expected that the medications, especially antibiotics be used completely, this trend indicates a higher possibility of emergence of resistant DEC strains due to exposure to the sub-lethal doses of these antibiotics as compared to children completing their dosages. This study concurs with several studies. For instance, Atif et al. (2019) showed that majority of patients, including pediatric patients, stopped the antibiotic course when they felt better and did not finish. Thus the ‘feeling better’ contributes significantly on inconsistent use of antibiotics.

Interestingly, it was observed that more than 90% of the children were under medications despite not having any symptoms of infections. This trend augments inappropriate use of antibiotics. It is expected that existence of active infections warrants the correct use of antibiotics. Cases of non-adherence to recommended antibiotic usage thus are the majority. As mentioned above, most antibiotics used in such medications are the β-lactams especially amoxicillin and ampicillin due to their affordability and availability. Thus, high number of usages of these antibiotics can be described by the need to ‘protect’ or ‘boost’ children’s immunity against the looming infections. The findings of the study however, further confirm the protective effect of using antibiotics only when sick against antimicrobial resistance. A report by Malik and Bhattacharyya (2019) indicates that combined effects of the economy, infections, and self-medication produce synergistic interactions through feedbacks on each other, portraying the evolution of drug resistance as a self-reinforcing loop in the population. Thus self-medication, compounded by other socio-economic factors, play a major role in the distribution of resistant strains. Other studies are further consistent with the current study (Ajibola et al., 2018; Gillani et al., 2017). There is however limited information on extent to which self-medication and without presentation of any symptoms among children.

Satisfaction levels on the use of antibiotics showed that majority of the parents were satisfied with the extent to which antibiotics were efficacious and beneficial to their children. The findings further showed a five-fold protective effect against antimicrobial resistance of being satisfied with medication. This could be explained by the positive effect of satisfaction to adherence to prescribed antibiotics and hence reduction in the cases of antibiotic resistance. Conversely, unsatisfaction on the effectiveness of antibiotics is one of the major potential risks associated with antimicrobial resistance. Conversely, Cohen et al. (2017) presumes that there is little strong evidence that patient satisfaction will lead to better medical results. Thus, patient satisfaction levels are based on the progression of the disease and the inherently equivocal and unstable character of human reactions. This means therefore that if there have been situations of improved child’s health after medication, there are higher chances that the subsequent prescriptions will be adhered.

With regards to finishing antibiotics, majority of the children completed their prescriptions of antibiotics fully. Only 7% did not finish their doses. Evidently, finishing a full prescription of antibiotics is not a risk factor for antimicrobial resistance. However, the 7% are seven times more likely to develop antimicrobial resistance. Therefore, findings have indicated that there is a seven-fold likelihood of developing antimicrobial resistance when one does not complete their prescriptions. From this study we can establish that sub-lethal exposure of bacteria is a major factor contributing to antimicrobial resistance. Jamhour et al. (2017) demonstrated that in developing nations, knowledge of antibiotics and self-medication techniques is a power driver of antimicrobial resistance. Most of the populations including the caregiver prefer not to use antibiotics to treat a cold. The study further demonstrated that the majority of the people did not prefer completing doses, instead keeping them for future use. This situation exacerbates emergence of antimicrobial resistant strains.

The decision to use antibiotics is solely dependent on the caregiver. The majority of the parents/guardians who participated in the study reported that they always make decisions on their own regarding when and how their children should use antibiotics. Informed decision seems to be a protective factor in the development and emergence of antimicrobial resistance. These decisions could be made based on the experience with antibiotic use. Interestingly, there is a probability slightly above 50% that the caregiver will make an informed decision regarding the use of antibiotics by their children. Nonetheless there exists a protective effect of making personal informed decisions on antimicrobial resistance. Boiko et al. (2020) demonstrated that expectations and experiences on antibiotic use constitute many reasons for the choices and decisions on the use of antibiotics.

Conclusion

The current study established an interplay of various factors associated to antimicrobial resistance among the DEC isolates. The results are consistent with almost all the studies that have been conducted to assess resistance patterns of DEC isolates. That is, first-line antibiotics such as amoxicillin, ampicillin and erythromycin almost always present the highest proportions of resistance. Also, it is explicit that self-medication is significantly associated with the escalating rates of resistance among children under five years of age.

Recommendations

This study recommends appropriate measures be taken to mitigate this trend. This can be done through formulation and implementation of more stringent antibiotic utilization policies. Finally, more robust techniques can be employed to assess the extent to which resistance of antibiotics is associated to molecular characteristics of the DEC strains.

Comments on this article Comments (1)

Version 1
VERSION 1 PUBLISHED 31 Aug 2023
  • Reader Comment 02 Nov 2023
    Yasir Elsanousi, Division of Tropical & Family Medicine, Alsabeel Charitable Health Center (SCHC), Sudan
    02 Nov 2023
    Reader Comment
    Thank you for the interesting article. The topic of antibiotic resistance and stewardship is a contemporary global concern. If I may contribute a few observations toward improving this important manuscript:
    ... Continue reading
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Suge T, Magu D and Wanzala P. Antibiotic utilization and resistance in diarrheagenic Escherichia coli isolated from children under 5 Years in Nakuru County: a case-control study [version 1; peer review: 2 not approved]. F1000Research 2023, 12:1072 (https://doi.org/10.12688/f1000research.130993.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 31 Aug 2023
Views
4
Cite
Reviewer Report 29 May 2024
Niels Frimodt-Møller, Rigshospitalet, Copenhagen, Denmark 
Not Approved
VIEWS 4
The paper by Suge et al. reports on an interesting subject of the relationship between antibiotic use and resistance in diarrheagenic E. coli in a district in Kenya. The study presented has, to be corrected or revised.

... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Frimodt-Møller N. Reviewer Report For: Antibiotic utilization and resistance in diarrheagenic Escherichia coli isolated from children under 5 Years in Nakuru County: a case-control study [version 1; peer review: 2 not approved]. F1000Research 2023, 12:1072 (https://doi.org/10.5256/f1000research.143796.r272516)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
9
Cite
Reviewer Report 11 Apr 2024
Benno H Ter Kuile, Laboratory for Molecular Biology and Microbial Food Safety, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands 
Not Approved
VIEWS 9
The major problem with this study is that the analytical procedure is not sufficiently clear described. The authors state that: “Cronbach’s Coefficient Alpha (α) of 0.75 was achieved which indicated that the instrument was reliable”. The instrument itself is, however, ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Kuile BHT. Reviewer Report For: Antibiotic utilization and resistance in diarrheagenic Escherichia coli isolated from children under 5 Years in Nakuru County: a case-control study [version 1; peer review: 2 not approved]. F1000Research 2023, 12:1072 (https://doi.org/10.5256/f1000research.143796.r259234)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (1)

Version 1
VERSION 1 PUBLISHED 31 Aug 2023
  • Reader Comment 02 Nov 2023
    Yasir Elsanousi, Division of Tropical & Family Medicine, Alsabeel Charitable Health Center (SCHC), Sudan
    02 Nov 2023
    Reader Comment
    Thank you for the interesting article. The topic of antibiotic resistance and stewardship is a contemporary global concern. If I may contribute a few observations toward improving this important manuscript:
    ... Continue reading
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.